Study reveals antidepressants most common medication for Australian women

Dec 16, 2008

(PhysOrg.com) -- A new study has revealed the most commonly prescribed medication for Australian women is antidepressants. The study, by researchers from Australian Longitudinal Study on Women's Health (ALSWH).

Pharmaceutical Benefits Scheme and Medicare data were linked to survey data to examine claims and costs of medications and other health care resources.

University of Newcastle study co-director and lead author of the Use and costs of medications and other health care resources report, Professor Julie Byles, said the research indicated the prevalence of antidepressant use increased with age.

“Eight percent of younger women and 14 percent of mid-age women used antidepressants during the surveyed period," Professor Byles said.

"This figure jumps to 18 percent in older women."

“However, the use of antidepressants is not a clear indicator of the extent of depression among women. For example, among young women who reported a diagnosis of depression, 40 percent had not used prescribed antidepressant medication.”

Other significant findings from the research include:

• Older women, in particular, mentioned the impact of of costs of medication on their ability to manage their incomes
• There were few differences in patterns of claims between women living in urban, rural and remote areas
• There was evidence that women who made claims for common medications had a lower socio-economic status.

The release of the report coincides with the Australian Government's announcement of a further $5 million to continue the longitudinal study for the next three and a half years. ALSWH has been funded by the Department of Health and Ageing since it commenced in 1996.

UQ ALSWH Director, Professor Annette Dobson, said the research provided an evidence-base to Government to assist health policy and programs to keep pace with the evolving needs of Australian women.

“The ongoing support of the Australian Government means the study's findings can continue to provide an invaluable insight into the biological, psychosocial and environmental factors affecting women across the course of life," Professor Dobson said.

The ALSWH is a 20 year project involving three cohorts spanning three generations. More than 40,000 women participate in the study. Researchers based in Newcastle work in collaboration with the Hunter Medical Research Institute. Use and costs of medications and other health care resources are available at www.alswh.org.au .

Provided by UQ

Explore further: First newborn screening test approved for rare immune disorder

add to favorites email to friend print save as pdf

Related Stories

Protections blocked, but sage grouse work goes on

46 minutes ago

(AP)—U.S. wildlife officials will decide next year whether a wide-ranging Western bird species needs protections even though Congress has blocked such protections from taking effect, Interior Secretary Sally Jewell said ...

Sprint accused of billing for unwanted services

55 minutes ago

(AP)—Federal regulators are accusing Sprint Corp. of illegally billing its wireless customers tens of millions of dollars in unwanted charges for text message alerts and other services.

Short-necked Triassic marine reptile discovered in China

57 minutes ago

A new species of short-necked marine reptile from the Triassic period has been discovered in China, according to a study published December 17, 2014 in the open-access journal PLOS ONE by Xiao-hong Chen f ...

Recommended for you

New system targets germs in donated blood plasma

11 hours ago

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

India court blocks Bayer generic drug appeal

Dec 13, 2014

An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.